First Time Loading...
G

Glenmark Life Sciences Ltd
NSE:GLS

Watchlist Manager
Glenmark Life Sciences Ltd
NSE:GLS
Watchlist
Price: 805.7 INR -1.14% Market Closed
Updated: Apr 29, 2024

Glenmark Life Sciences Ltd
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Glenmark Life Sciences Ltd
Cash from Financing Activities Peer Comparison

Comparables:
DRREDDY
CIPLA
SUNPHARMA
ZYDUSLIFE
M
MANKIND

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
G
Glenmark Life Sciences Ltd
NSE:GLS
Cash from Financing Activities
-₹3.9B
CAGR 3-Years
-42%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Cash from Financing Activities
-₹12.2B
CAGR 3-Years
0%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Cash from Financing Activities
-₹11.5B
CAGR 3-Years
-1%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Cash from Financing Activities
-₹54.6B
CAGR 3-Years
-8%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
Cash from Financing Activities
-₹29.8B
CAGR 3-Years
-40%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
M
Mankind Pharma Ltd
NSE:MANKIND
Cash from Financing Activities
-₹7.4B
CAGR 3-Years
-12%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Glenmark Life Sciences Ltd's Cash from Financing Activities?
Cash from Financing Activities
-3.9B INR

Based on the financial report for Mar 31, 2023, Glenmark Life Sciences Ltd's Cash from Financing Activities amounts to -3.9B INR.

What is Glenmark Life Sciences Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 3Y
-42%

Over the last year, the Cash from Financing Activities growth was -392%. The average annual Cash from Financing Activities growth rates for Glenmark Life Sciences Ltd have been -42% over the past three years .